4 ms·
Stop spreading disinformation. This has gone through studies showing significant positive benefits. Ivermectin has small studies with dubious methodology showin
by acdha 5y ago
Stop spreading disinformation. This has gone through studies showing significant positive benefits. Ivermectin has small studies with dubious methodology showing possible effects and larger studies with better methodology showing no benefit, along with substantial side-effects.
https://ebm.bmj.com/content/early/2021/05/26/bmjebm-2021-111678 https://ebm.bmj.com/content/early/2021/05/26/bmjebm-2021-111...
https://www.cochranelibrary.com/content?templateType=full&urlTitle=/cdsr/doi/10.1002/14651858.CD015017.pub2&doi=10.1002/14651858.CD015017.pub2&type=cdsr&contentLanguage= https://www.cochranelibrary.com/content?templateType=full&ur...
- isolli 5y agoI don't know if ivermectin is efficient, but I doubt it has substantial side-effects. Your first link states that ivermectin is "proved to be safe at the conventional dose, although severe adverse effects have occasionally been reported". Occasional is not "substantial". Your second link does not work for me.
- acdha 5y agoThe people pushing it as a COVID treatment are usually pushing prolonged usage at higher doses – they routinely dismiss studies showing no benefits as not using enough – and the documented side effects definitely happen at those levels. The lower doses used for parasite treatments also are balanced against high efficacy, whereas this just means you still have COVID along with new problems. Sorry about the link - it worked earlier when I tested it. You can try this one: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD015017.pub2/full https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD...
- isolli 5y agoThanks for the updated link. What I read is: "Ivermectin has few unwanted effects." I don't think (and you also seem to imply) that any of the studies conducted for Covid were using much higher doses than the standard. On the contrary, this was precisely the point of clinical studies: to determine whether a standard dose of ivermectin (with known and limited side effects) would provide benefits, even though it is lower than the dose at which ivermectin was initially shown to have antiviral properties in vitro.
- Izkata 5y ago> The people pushing it as a COVID treatment are usually pushing prolonged usage at higher doses – they routinely dismiss studies showing no benefits as not using enough – and the documented side effects definitely happen at those levels. Uh, I have never seen that from them. All of them say the bad studies are the ones using too high a dosage, and the side effects from that dosage are why those studies have bad results.
- pjkundert 5y agoYou are misinformed: c19early.com c19ivermectin.com 128 studies, 83 peer-reviewed. The money quote, from ivmmeta.com: - There is evidence of a negative publication bias, and the probability that an ineffective treatment generated results as positive as the 65 studies is estimated to be 1 in 403 billion. So, ... stop spreading misinformation?
- thehappypm 5y agoCan you find a neutral source? I’m really interested in ivermectin but nobody posts anything from neutral web sites.
- pjkundert 5y agoSo, you don't want to review the 128 independent studies, 89 peer-reviewed -- you want me to find you more neutral sources? You're on your own, buddy! :)
- thehappypm 5y agoI don’t like to click links to random web sites I haven’t heard of.
- acdha 5y agoNo, I’m not. You’re citing notorious disinformation sites whose anonymous creators are relying on you seeing big numbers and not noticing the problems with methodology and analysis. When actual experts look at those studies, the results have not held up. https://ebm.bmj.com/content/early/2021/05/26/bmjebm-2021-111678 https://ebm.bmj.com/content/early/2021/05/26/bmjebm-2021-111... > Different websites (such as https://ivmmeta.com/ https://ivmmeta.com/, https://c19ivermectin.com/ https://c19ivermectin.com/, https://tratamientotemprano.org/estudios-ivermectina/ https://tratamientotemprano.org/estudios-ivermectina/, among others) have conducted meta-analyses with ivermectin studies, showing unpublished colourful forest plots which rapidly gained public acknowledgement and were disseminated via social media, without following any methodological or report guidelines. These websites do not include protocol registration with methods, search strategies, inclusion criteria, quality assessment of the included studies nor the certainty of the evidence of the pooled estimates. Prospective registration of systematic reviews with or without meta-analysis protocols is a key feature for providing transparency in the review process and ensuring protection against reporting biases, by revealing differences between the methods or outcomes reported in the published review and those planned in the registered protocol. These websites show pooled estimates suggesting significant benefits with ivermectin, which has resulted in confusion for clinicians, patients and even decision-makers. This is usually a problem when performing meta-analyses which are not based in rigorous systematic reviews, often leading to spread spurious or fallacious findings. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8050401 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8050401 > Meta-analysis/observational studies (https://ivmmeta.com https://ivmmeta.com) are circulating in the scientific community and over the Internet, demonstrating the efficacy of IVM during the pandemic. However, most of the listed references fail to provide adequate methodologies, making them difficult to be validated. Major limitations include, small sample sizes, doses and frequency of IVM use, open-label studies, in which neither the participants nor the investigators were blinded to the treatments, the use of concomitant medications in addition to IVM, assuming that the efficacy resulted from IVM (https://www.covid19treatmentguidelines.nih.gov/antiviral-therapy/ivermectin/ https://www.covid19treatmentguidelines.nih.gov/antiviral-the...).